TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

  1. Home
  2. purchase Customization

purchase customization

Leave This Empty:

choose chapter to purchase


Back to Report

table of content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COVID-19 Molecular Diagnostics Market Size Growth Rate by Type (2022-2028)
1.2.2 High-throughput Sequencing
1.2.3 Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
1.2.4 Immunological Detection
1.3 Market by Application
1.3.1 Global COVID-19 Molecular Diagnostics Market Share by Application (2022-2028)
1.3.2 Hospitals
1.3.3 Scientific Research
1.3.4 Biodiagnostics
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global COVID-19 Molecular Diagnostics Market Size
2.2 COVID-19 Molecular Diagnostics Market Size by Regions
2.2.1 COVID-19 Molecular Diagnostics Growth Rate by Regions (2022-2028)
2.2.2 COVID-19 Molecular Diagnostics Market Share by Regions (2022-2028)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 COVID-19 Molecular Diagnostics Revenue by Players (2022 & 2028)
3.2 COVID-19 Molecular Diagnostics Key Players Headquarters and Area Served
3.3 Key Players COVID-19 Molecular Diagnostics Product/Solution/Service
3.4 Date of Enter into COVID-19 Molecular Diagnostics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and by Application
4.1 Global COVID-19 Molecular Diagnostics Market Size by Type (2022-2028)
4.2 Global COVID-19 Molecular Diagnostics Market Size by Application (2022-2028)
5 North America
5.1 North America COVID-19 Molecular Diagnostics Market Forecast (2022-2028)
5.2 COVID-19 Molecular Diagnostics Key Players in North America
5.3 North America COVID-19 Molecular Diagnostics Market Size by Type
5.4 North America COVID-19 Molecular Diagnostics Market Size by Application
6 Europe
6.1 Europe COVID-19 Molecular Diagnostics Market Forecast (2022-2028)
6.2 COVID-19 Molecular Diagnostics Key Players in Europe
6.3 Europe COVID-19 Molecular Diagnostics Market Size by Type
6.4 Europe COVID-19 Molecular Diagnostics Market Size by Application
7 Asia-Pacific
7.1 Asia-Pacific COVID-19 Molecular Diagnostics Market Forecast (2022-2028)
7.2 COVID-19 Molecular Diagnostics Key Players in Asia-Pacific
7.3 Asia-Pacific COVID-19 Molecular Diagnostics Market Size by Type
7.4 Asia-Pacific COVID-19 Molecular Diagnostics Market Size by Application
8 Rest of World
8.1 Latin America
8.1.1 Latin America COVID-19 Molecular Diagnostics Market Analysis
8.1.2 Key Players in Latin America
8.2 Middle East & Africa
8.2.1 Middle East & Africa COVID-19 Molecular Diagnostics Market Analysis
8.2.2 Key Players in Middle East & Africa
9 International Player Profiles
9.1 Cellex
9.1.1 Cellex Company Details
9.1.2 Cellex Description and Business Overview
9.1.3 Cellex COVID-19 Molecular Diagnostics Introduction
9.1.4 Cellex Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.1.5 Cellex Recent Development
9.2 Abbott
9.2.1 Abbott Company Details
9.2.2 Abbott Description and Business Overview
9.2.3 Abbott COVID-19 Molecular Diagnostics Introduction
9.2.4 Abbott Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.2.5 Abbott Recent Development
9.3 Roche
9.3.1 Roche Company Details
9.3.2 Roche Description and Business Overview
9.3.3 Roche COVID-19 Molecular Diagnostics Introduction
9.3.4 Roche Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.3.5 Roche Recent Development
9.4 BioMedomics
9.4.1 BioMedomics Company Details
9.4.2 BioMedomics Description and Business Overview
9.4.3 BioMedomics COVID-19 Molecular Diagnostics Introduction
9.4.4 BioMedomics Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.4.5 BioMedomics Recent Development
9.5 BD
9.5.1 BD Company Details
9.5.2 BD Description and Business Overview
9.5.3 BD COVID-19 Molecular Diagnostics Introduction
9.5.4 BD Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.5.5 BD Recent Development
9.6 Henry Schein
9.6.1 Henry Schein Company Details
9.6.2 Henry Schein Description and Business Overview
9.6.3 Henry Schein COVID-19 Molecular Diagnostics Introduction
9.6.4 Henry Schein Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.6.5 Henry Schein Recent Development
9.7 Safecare Bio-Tech
9.7.1 Safecare Bio-Tech Company Details
9.7.2 Safecare Bio-Tech Description and Business Overview
9.7.3 Safecare Bio-Tech COVID-19 Molecular Diagnostics Introduction
9.7.4 Safecare Bio-Tech Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.7.5 Safecare Bio-Tech Recent Development
9.8 Thermo Fisher
9.8.1 Thermo Fisher Company Details
9.8.2 Thermo Fisher Description and Business Overview
9.8.3 Thermo Fisher COVID-19 Molecular Diagnostics Introduction
9.8.4 Thermo Fisher Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.8.5 Thermo Fisher Recent Development
9.9 Bio-rad
9.9.1 Bio-rad Company Details
9.9.2 Bio-rad Description and Business Overview
9.9.3 Bio-rad COVID-19 Molecular Diagnostics Introduction
9.9.4 Bio-rad Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.9.5 Bio-rad Recent Development
9.10 Agilent
9.10.1 Agilent Company Details
9.10.2 Agilent Description and Business Overview
9.10.3 Agilent COVID-19 Molecular Diagnostics Introduction
9.10.4 Agilent Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.10.5 Agilent Recent Development
9.11 Ortho Clinical Diagnostics
9.11.1 Ortho Clinical Diagnostics Company Details
9.11.2 Ortho Clinical Diagnostics Description and Business Overview
9.11.3 Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Introduction
9.11.4 Ortho Clinical Diagnostics Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.11.5 Ortho Clinical Diagnostics Recent Development
9.12 Zhejiang Orient Gene Biotech
9.12.1 Zhejiang Orient Gene Biotech Company Details
9.12.2 Zhejiang Orient Gene Biotech Description and Business Overview
9.12.3 Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Introduction
9.12.4 Zhejiang Orient Gene Biotech Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.12.5 Zhejiang Orient Gene Biotech Recent Development
9.13 Innovita Biological Technology
9.13.1 Innovita Biological Technology Company Details
9.13.2 Innovita Biological Technology Description and Business Overview
9.13.3 Innovita Biological Technology COVID-19 Molecular Diagnostics Introduction
9.13.4 Innovita Biological Technology Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.13.5 Innovita Biological Technology Recent Development
9.14 Guangzhou Wondfo Biotech
9.14.1 Guangzhou Wondfo Biotech Company Details
9.14.2 Guangzhou Wondfo Biotech Description and Business Overview
9.14.3 Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Introduction
9.14.4 Guangzhou Wondfo Biotech Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.14.5 Guangzhou Wondfo Biotech Recent Development
9.15 Guangdong Hecin-Scientific
9.15.1 Guangdong Hecin-Scientific Company Details
9.15.2 Guangdong Hecin-Scientific Description and Business Overview
9.15.3 Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Introduction
9.15.4 Guangdong Hecin-Scientific Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.15.5 Guangdong Hecin-Scientific Recent Development
9.16 Dynamiker Biotechnology (Tianjin)
9.16.1 Company Details
9.16.2 Dynamiker Biotechnology (Tianjin) Description and Business Overview
9.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Introduction
9.16.4 Dynamiker Biotechnology (Tianjin) Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.16.5 Dynamiker Biotechnology (Tianjin) Recent Development
9.17 ADVAITE
9.17.1 ADVAITE Company Details
9.17.2 ADVAITE Description and Business Overview
9.17.3 ADVAITE COVID-19 Molecular Diagnostics Introduction
9.17.4 ADVAITE Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.17.5 ADVAITE Recent Development
9.18 Mayo Clinic Laboratories
9.18.1 Mayo Clinic Laboratories Company Details
9.18.2 Mayo Clinic Laboratories Description and Business Overview
9.18.3 Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Introduction
9.18.4 Mayo Clinic Laboratories Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.18.5 Mayo Clinic Laboratories Recent Development
9.19 Chembio Diagnostics
9.19.1 Chembio Diagnostics Company Details
9.19.2 Chembio Diagnostics Description and Business Overview
9.19.3 Chembio Diagnostics COVID-19 Molecular Diagnostics Introduction
9.19.4 Chembio Diagnostics Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.19.5 Chembio Diagnostics Recent Development
9.20 Mount Sinai Laboratory
9.20.1 Mount Sinai Laboratory Company Details
9.20.2 Mount Sinai Laboratory Description and Business Overview
9.20.3 Mount Sinai Laboratory COVID-19 Molecular Diagnostics Introduction
9.20.4 Mount Sinai Laboratory Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.20.5 Mount Sinai Laboratory Recent Development
9.21 QIAGEN
9.21.1 QIAGEN Company Details
9.21.2 QIAGEN Description and Business Overview
9.21.3 QIAGEN COVID-19 Molecular Diagnostics Introduction
9.21.4 QIAGEN Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.21.5 QIAGEN Recent Development
9.22 Bioer
9.22.1 Bioer Company Details
9.22.2 Bioer Description and Business Overview
9.22.3 Bioer COVID-19 Molecular Diagnostics Introduction
9.22.4 Bioer Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.22.5 Bioer Recent Development
9.23 Biosynex
9.23.1 Biosynex Company Details
9.23.2 Biosynex Description and Business Overview
9.23.3 Biosynex COVID-19 Molecular Diagnostics Introduction
9.23.4 Biosynex Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.23.5 Biosynex Recent Development
9.24 Esco
9.24.1 Esco Company Details
9.24.2 Esco Description and Business Overview
9.24.3 Esco COVID-19 Molecular Diagnostics Introduction
9.24.4 Esco Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.24.5 Esco Recent Development
9.25 Analytik Jena
9.25.1 Analytik Jena Company Details
9.25.2 Analytik Jena Description and Business Overview
9.25.3 Analytik Jena COVID-19 Molecular Diagnostics Introduction
9.25.4 Analytik Jena Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.25.5 Analytik Jena Recent Development
9.26 Techne
9.26.1 Techne Company Details
9.26.2 Techne Description and Business Overview
9.26.3 Techne COVID-19 Molecular Diagnostics Introduction
9.26.4 Techne Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.26.5 Techne Recent Development
9.27 Da An Gene
9.27.1 Da An Gene Company Details
9.27.2 Da An Gene Description and Business Overview
9.27.3 Da An Gene COVID-19 Molecular Diagnostics Introduction
9.27.4 Da An Gene Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.27.5 Da An Gene Recent Development
9.28 BGI
9.28.1 BGI Company Details
9.28.2 BGI Description and Business Overview
9.28.3 BGI COVID-19 Molecular Diagnostics Introduction
9.28.4 BGI Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.28.5 BGI Recent Development
9.29 Shanghai ZJ Bio-Tech
9.29.1 Shanghai ZJ Bio-Tech Company Details
9.29.2 Shanghai ZJ Bio-Tech Description and Business Overview
9.29.3 Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Introduction
9.29.4 Shanghai ZJ Bio-Tech Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.29.5 Shanghai ZJ Bio-Tech Recent Development
10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details